Preventing SARS-CoV-2 infection by blocking a tissue serine protease

Preventing SARS-CoV-2 infection by blocking a tissue serine protease

Currently, there are no proven pharmacologic interventions to reduce the clinical impact and prevent complications of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, the cause of the ongoing Coronavirus Disease of 2019 (COVID-19) pandemic. Selecting specific pharmacologic...

Full description

Bibliographic Details
Main Authors: Katherine C. Jankousky, Jonathan Schultz, Samuel Windham, Andrés F. Henao-Martínez, Carlos Franco-Paredes, Leland Shapiro
Format: Article
Language:English
Published: SAGE Publishing 2020-06-01
Series:Therapeutic Advances in Infectious Disease
Online Access:https://doi.org/10.1177/2049936120933076

Internet

https://doi.org/10.1177/2049936120933076

Similar Items